{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:29:21Z","timestamp":1773167361395,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.arcmed.2008.10.004","type":"journal-article","created":{"date-parts":[[2008,12,8]],"date-time":"2008-12-08T05:30:11Z","timestamp":1228714211000},"page":"59-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Inhibition of Corneal Neovascularization with Propolis Extract"],"prefix":"10.1016","volume":"40","author":[{"given":"Maryam","family":"Keshavarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Mostafaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadollah","family":"Shakiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza Mohammadi","family":"Motlagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2008.10.004_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization. An epidemiologic review","volume":"433","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.arcmed.2008.10.004_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archopht.1981.03930010599002","article-title":"Clinical types of corneal transplant rejection their manifestations, frequency, preoperative correlates, and treatment","volume":"994","author":"Alldredge","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.arcmed.2008.10.004_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"124","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.arcmed.2008.10.004_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/348555a0","article-title":"Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth","volume":"348","author":"Ingber","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2008.10.004_bib5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1006\/exer.1997.0292","article-title":"Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization","volume":"646","author":"Kenyon","year":"1997","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.arcmed.2008.10.004_bib6","first-page":"274","article-title":"Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A","volume":"382","author":"Benelli","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2008.10.004_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1248\/bpb.24.151","article-title":"Demonstration of inhibitory effect of oral shark cartilage on basic fibroblast growth factor-induced angiogenesis in the rabbit cornea","volume":"24","author":"Gonzales","year":"2001","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.arcmed.2008.10.004_bib8","first-page":"228","article-title":"Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization","volume":"952","author":"Huang","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.arcmed.2008.10.004_bib9","first-page":"137","article-title":"Tumor-induced angiogenesis: a review","volume":"5","author":"Plank","year":"2004","journal-title":"J Theor Med"},{"key":"10.1016\/j.arcmed.2008.10.004_bib10","series-title":"Methods in Molecular Medicine: Angiogenesis Protocols","author":"Murray","year":"2001"},{"key":"10.1016\/j.arcmed.2008.10.004_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2008.10.004_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.a.10032","article-title":"In vitro model of wound healing analyzed by laser scanning cytometry: accelerated healing of epithelial cell monolayer in the presence of hyaluronate","volume":"53A","author":"Haider","year":"2003","journal-title":"Cytometry Part A"},{"key":"10.1016\/j.arcmed.2008.10.004_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.ph.49.030187.002321","article-title":"Mechanism of angiogenesis","volume":"49","author":"D'Amore","year":"1987","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.arcmed.2008.10.004_bib14","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1167\/iovs.04-1172","article-title":"Flt-1 intraceptors inhibits hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo","volume":"465","author":"Singh","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2008.10.004_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","article-title":"Vascular endothelial growth factor VEGF and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing","volume":"825","author":"Gan","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.arcmed.2008.10.004_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1167\/iovs.01-1277","article-title":"VEGF-dependent conjunctivalization of the corneal surface","volume":"441","author":"Joussen","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2008.10.004_bib17","first-page":"426","article-title":"Antisense vascular endothelial growth factor suppressed corneal neovascularization in rats","volume":"425","author":"Zhou","year":"2006","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10.1016\/j.arcmed.2008.10.004_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02713680500514636","article-title":"Inhibition of ocular angiogenesis by diced small interfering RNAs siRNAs specific to vascular endothelial growth factor VEGF","volume":"312","author":"Murata","year":"2006","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.arcmed.2008.10.004_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1006\/exer.2002.2075","article-title":"Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA","volume":"756","author":"Lai","year":"2002","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.arcmed.2008.10.004_bib20","first-page":"203","article-title":"Expression of vascular endothelial growth factor and its receptors flt-1 in morbid human corneas and investigation of its clinic importance","volume":"184","author":"Chen","year":"2002","journal-title":"Yan Ke Xue Bao"},{"key":"10.1016\/j.arcmed.2008.10.004_bib21","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization","volume":"391","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2008.10.004_bib22","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Paul Aiello","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.arcmed.2008.10.004_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-200502000-00001","article-title":"The role of vascular endothelial growth factor in ocular health and disease","volume":"252","author":"Adamis","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.arcmed.2008.10.004_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0168-9525(90)90126-Q","article-title":"Metalloproteinases and their inhibitors in matrix remodeling","volume":"6","author":"Matrisian","year":"1990","journal-title":"Trends Genet"},{"key":"10.1016\/j.arcmed.2008.10.004_bib25","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/bjo.84.6.654","article-title":"Matrix metalloproteinase biology applied to vitreoretinal disorders","volume":"84","author":"Sethi","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.arcmed.2008.10.004_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(01)02897-6","article-title":"Diminished corneal angiogenesis in gelatinase A-deficient mice","volume":"5082","author":"Kato","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcmed.2008.10.004_bib27","first-page":"955","article-title":"Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis","volume":"434","author":"Zhang","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2008.10.004_bib28","first-page":"685","article-title":"Corneal burns and matrix metalloproteinases MMP-2 and -9: the effects of human amniotic membrane transplantation","volume":"257","author":"Rigal-Sastourne","year":"2002","journal-title":"J\u00a0Fr Ophtalmol"},{"key":"10.1016\/j.arcmed.2008.10.004_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000055693","article-title":"Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization","volume":"336","author":"Ma","year":"2001","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.arcmed.2008.10.004_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.exer.2004.08.023","article-title":"Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice","volume":"802","author":"Samolov","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.arcmed.2008.10.004_bib31","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1167\/iovs.03-0249","article-title":"Reduced retinal angiogenesis in MMP-2-deficient mice","volume":"44","author":"Ohno-Matsui","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2008.10.004_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1167\/iovs.02-0180","article-title":"Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice","volume":"441","author":"Berglin","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2008.10.004_bib33","first-page":"49","article-title":"Propolis: biological and pharmacological activities. Therapeutic uses of this bee-product","volume":"3","author":"De Castro SL","year":"2001","journal-title":"Annu Rev Biomed Sci"},{"key":"10.1016\/j.arcmed.2008.10.004_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1051\/apido:19950202","article-title":"Propolis: chemical composition, biological properties and therapeutic activity","volume":"26","author":"Marcucci","year":"1995","journal-title":"Apidologie"},{"key":"10.1016\/j.arcmed.2008.10.004_bib35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.lfs.2006.09.017","article-title":"Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions","volume":"80","author":"Nakajima","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.arcmed.2008.10.004_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0278-6915(97)00145-2","article-title":"Review of the biological properties and toxicity of bee propolis (Propolis)","volume":"36","author":"Burdock","year":"1988","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.arcmed.2008.10.004_bib37","first-page":"1255","article-title":"Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester","volume":"53","author":"Frenkel","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2008.10.004_bib38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jnutbio.2005.08.009","article-title":"Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells","volume":"17","author":"Hwang","year":"2006","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.arcmed.2008.10.004_bib39","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000055567","article-title":"Topically applied water extract of propolis to suppress corneal neovascularization in rabbits","volume":"31","author":"Hep\u015fen","year":"1999","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.arcmed.2008.10.004_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cccn.2005.05.009","article-title":"Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification","volume":"362","author":"Jin","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arcmed.2008.10.004_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2005.03.046","article-title":"Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo","volume":"234","author":"Kuoa","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.arcmed.2008.10.004_bib42","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1021\/jf034729d","article-title":"Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis","volume":"51","author":"Liao","year":"2003","journal-title":"J Agr Food Chem"},{"key":"10.1016\/j.arcmed.2008.10.004_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.canlet.2006.12.039","article-title":"suppression of tumor-induced angiogenesis by Brazilian propolis: major component artepillin C inhibits in vitro tube formation and endothelial cell proliferation","volume":"252","author":"Ahn","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.arcmed.2008.10.004_bib44","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1515\/znc-1989-11-1231","article-title":"Antitumoral property of ethanolic extract of propolis in mice-bearing Ehrlich carcinoma, as compared to bleomycin","volume":"44c","author":"Scheller","year":"1989","journal-title":"Z Naturforsch"},{"key":"10.1016\/j.arcmed.2008.10.004_bib45","first-page":"583","article-title":"A tumoricidal and antioxidant compound isolated from an aqueous extract of propolis","volume":"25","author":"Matsuno","year":"1997","journal-title":"Med Sci Res"},{"key":"10.1016\/j.arcmed.2008.10.004_bib46","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1525-1500.1998.00020.x","article-title":"Apoptosis and suppression of tumor growth by artepillin C extracted from Brazilian propolis","volume":"22","author":"Kimoto","year":"1998","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.arcmed.2008.10.004_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.canlet.2005.09.002","article-title":"Dietary artepillin C suppresses the formation of aberrant crypt foci induced by azoxymethane in mouse colon","volume":"240","author":"Shimizua","year":"2006","journal-title":"Cancer Lett"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844090800249X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844090800249X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:36:29Z","timestamp":1759260989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018844090800249X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S018844090800249X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2008.10.004","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Corneal Neovascularization with Propolis Extract","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2008.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}